Phase Ib Trial of Two Folate Binding Protein (FBP) Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
Phase of Trial: Phase I/II
Latest Information Update: 15 May 2019
Price : $35 *
At a glance
- Drugs GALE 301 (Primary) ; GALE 302 (Primary)
- Indications Breast cancer; Ovarian cancer
- Focus Therapeutic Use
- Sponsors Galena Biopharma
- 31 Aug 2018 Biomarkers information updated
- 09 Mar 2017 Status changed from active, no longer recruiting to completed, as reported in a Galena Biopharma media release.
- 12 Dec 2016 According to a Galena Biopharma media release, data from this study were presented as a poster at the San Antonio Breast Cancer Symposium (SABCS).